Fellows
Pavan Bhamidipati.jpg

Pavan K. Bhamidipati, MD

Second-year Fellow (entered program in 2015)

Clinical Focus

  • Hematologic malignancies (leukemia, lymphoma and myeloma
  • Bone marrow transplantation

Research Focus

  • Relapsed leukemia
  • Graft vs host disease
  • Allogeneic stem cell transplantation

Type of Research

  • Clinical research/outcomes research

Profile

Education
MD, Guntur Medical College, Guntur, India
Post-graduate Training
Residency, Central Michigan University, Saginaw, MI

Publications

  • Transplant outcomes in older patients are comparable to outcomes in younger patients after Hopkin's non-myeloablative Flu Cy TBI + PT-Cy regimen
    Keller J, DiPersio JF, Uy GL, Westervelt P, Abboud C, Bhamidipati PK, Vij R, Cashen A, Trinkaus K, Romee R
    Biol Blood Marrow Transplant 2015;21(2)Suppl:S294
  • Conservative management of pneumatosis intestinalis after allogeneic hematopoietic SCT
    Bhamidipati PK, Ghobadi A, Bauer S, DiPersio JF, Pusic I
    Bone Marrow Transplant 2014 Nov;49(11):1436-8
  • Haploidentical transplantation using G-CSF-mobilized T-cell replete PBSCs and post-transplantation CY after non-myeloablative conditioning is safe and is associated with favorable outcomes
    Bhamidipati PK, DiPersio JF, Stokerl-Goldstein K, Rashidi A, Gao F, Uy GL, Westervelt P, Vij R, Schroeder MA, Abboud CN, Keller JW, Fehniger TA, Romee R
    Bone Marrow Transplant 2014 Aug;49(8):1124-6
  • Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen
    Manjappa S, Bhamidipati PK, Stokerl-Goldstein KE, DiPersio JF, Uy GL, Westervelt P, Liu J, Schroeder MA, Vij R, Abboud CN, Fehniger TA, Cashen AF, Pusic I, Jacoby M, Meera SJ, Romee R
    Biol Blood Marrow Transplant 2014 Jan;20(1):46-52
  • Epstein-Barr virus-induced CD30-positive diffuse large B-cell lymphoma in a patient with mixed-phenotypic leukemia treated with clofarabine
    Bhamidipati PK, Jabbour E, Konoplev S, Estrov Z, Cortes J, Daver N
    Clin Lymphoma Myeloma Leuk 2013 Jun;13(3):342-6
  • Management of imatinib-resistant patients with chronic myeloid leukemia
    Bhamidipati PK, Kantarjian H, Cortes J, Cornelison AM, Jabbour E
    Ther Adv Hematol 2013 Apr;4(2):103-17
  • An Atypical Presentation with Diagnostic Challenge of a Large Cell Neuroendocrine Cancer of Lung: A Case Report and Review of the Literature
    Bhamidipati PK, Ribbeck A, Liaghati-Nasseri G, Kumar R, Paidipaty B B, Bartnik J
    Lung Cancer Int 2011;2011:912098

Oral Abstract

  • T-cell replete peripheral blood stem cell transplantation after non-myeloablative conditioning with post-transplant high dose cyclophosphamide is safe and is associated with acceptable outcomes
    Bhamidipati PK, DiPersio JF, Stockerl-Goldstein K, Rashidi A, Gao F, Uy GL, Westervelt P, Vij R, Schroeder MA, Abboud CN, Keller JW, Fehniger TA, Romee R
    BMT Tandem "Scientific" Meeting, Dallas, TX, 2014 (Session A, Abstract 10)

Poster Abstracts

  • The impact of CD34+ cell dose and comorbidities on engraftment following autologous hematopoietic stem cell transplantation (ASCT)
    Fiala MA, Bhamidipati PK, Wang S, Sturgill T, Gao F, Abboud CN, Cashen AF, Jacoby MA, Pusic I, Romee R, Schroeder MA, Uy GL, Vij R, Westervelt P, DiPersio JF, Stockerl-Goldstein K
    J Clin Oncol 2014;32:5s (suppl; abstr 7046)
  • Outcomes after second allogeneic hematopoietic stem cell transplantation: a single-center experience
    Touma W, Koro SS, Bhamidipati PK, Manjappa S, Romee R, Pusic I, Uy GL, Cashen AF, Stockerl-Goldstein K, Westervelt P, Abboud CN, Vij R, DiPersio JF, Schroeder MA
    J Clin Oncol 2014;32:5s (suppl; abstr 7018)
  • FLT3 mutations in myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML)
    Bhamidipati PK, Daver NG, Kantarjian H, Pierce S, Daver R, Cortes JE, Ravandi F, Mathisen M, Pemmaraju N, Nazha A, Kadia TM, Jabbour E, Borthakur E, Faderl S, Garcia-Manero G
    J Clin Oncol 2012;30 (suppl; abstr 6597)
  • Haploidentical peripheral blood stem cell transplantation using non-myeloablative conditioning with post-transplant cyclophosphamide regimen is safe and is associated with very encouraging post-transplant outcomes
    Bhamidipati PK, DiPersio JF, Stockerl-Goldstein K, Rashidi A, Gao F, Uy GL, Westervelt P, Vij R, Schroeder MA, Abboud CN, Keller JW, Fehniger TA, Romee R
    Blood 2013;122(21):4532.
  • Predicting autologous stem cell mobilization failure in hematologic malignancies
    Fiala MA, Bhamidipati PK, Wang S, Sturgill T, Gao F, Abboud CN, Cashen AF, Jacoby MA, Pusic I, Romee R, Schroeder MA, Uy GL, Vij R, Westervelt P, DiPersio JF, Stockerl-Goldstein K
    Blood 2013;122(21):2034
  • Pegasparginase induced hyperbilirubinemia, hypertriglyceridemia and acute pancreatitis
    Bhamidipati PK, Vallabhaneni S, Jabbour E, Borthakur G
    ACP National Meeting (Apr 2012)
  • A rare and lethal cause of hematuria that lead to the diagnosis of sickle cell trait
    Bhamidipati PK, Vallabhaneni S, Paidipaty BB, Jensen SL, Liu BF
    ACP National Meeting (Apr 2012)
  • Effect of cyberknife therapy in patients with non-small cell lung cancer
    Bhamidipati PK, Vallabhaneni S, Paidipaty BB, Young K
    ACP, May 2012

Book Chapters

  • Front line therapy
    Bhamidipati PK, Jabbour E
    In: C Ustun and UR Popat (Ed), Chronic Myeloid Leukemia: From Daily Management to Complicated Issues, Nova Science Publishers, 2013, pp 107-128
  • Management of tyrosine kinase inhibitors resistance
    Bhamidipati PK, Jabbour E
    In: C Ustun and UR Popat (Ed), Chronic Myeloid Leukemia: From Daily Management to Complicated Issues, Nova Science Publishers, 2013, pp 129-156
  • Management of chronic myeloid leukemia (CML): blast phase (BP)
    Bhamidipati PK, Al-Kali A, Jabbour E
    In: C Ustun and UR Popat (Ed), Chronic Myeloid Leukemia: From Daily Management to Complicated Issues, Nova Science Publishers, 2013, pp 167-174
  • Personalized medicine and targeted therapy of leukemia
    Bhamidipati PK, Jabbour E, Cortes J
    In: D Tan, HT Lynch (Ed), Principles of Molecular Diagnostics and Personalized Cancer Medicine, Lippincott Williams & Wilkins, 2013, pp 600-630